QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Colorectal Cancer|Breast Cancer|Head and Neck Squamous Cell Carcinoma|Melanoma|Non Small Cell Lung Cancer|Pancreatic Cancer|Liver Cancer
Interventions: BIOLOGICAL: YE-NEO-001
Sponsor: NantBioScience, Inc.